Publicacións nas que colabora con Francisco Blanco García (91)

2024

  1. Prognostic model to predict the incidence of radiographic knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 5, pp. 661-668

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. An Atlas of the Knee Joint Proteins and Their Role in Osteoarthritis Defined by Literature Mining

    Molecular and Cellular Proteomics, Vol. 22, Núm. 8

  3. Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project

    Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115

  4. Proteomic profiling of human menisci from mild joint degeneration and end-stage osteoarthritis versus healthy controls

    Osteoarthritis and Cartilage Open, Vol. 5, Núm. 4

2022

  1. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

    Frontiers in Medicine, Vol. 9

2021

  1. A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

    Osteoarthritis and Cartilage, Vol. 29, Núm. 8, pp. 1147-1154

  2. Identification of a distinct lipidomic profile in the osteoarthritic synovial membrane by mass spectrometry imaging

    Osteoarthritis and Cartilage, Vol. 29, Núm. 5, pp. 750-761

  3. Nucleic Acid Programmable Protein Arrays (NAPPA) for the Discovery of Autoantibodies in Osteoarthritis

    Methods in Molecular Biology (Humana Press Inc.), pp. 181-190

  4. Serum Proteomic Profiling in Rheumatoid Arthritis by Antibody Suspension Bead Arrays

    Methods in Molecular Biology (Humana Press Inc.), pp. 143-151

  5. Targeted phospholipidomic analysis of synovial fluid as a tool for osteoarthritis deep phenotyping

    Osteoarthritis and Cartilage Open, Vol. 3, Núm. 4

2020

  1. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

  2. Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

    Molecular and Cellular Proteomics, Vol. 19, Núm. 4, pp. 574-588

2019

  1. Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers

    Molecular and Cellular Proteomics, Vol. 18, Núm. 10, pp. 2018-2028

  2. Discovery of an autoantibody signature for the early diagnosis of knee osteoarthritis: Data from the Osteoarthritis Initiative

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 12, pp. 1699-1705

  3. Mining the Proteome Associated with Rheumatic and Autoimmune Diseases

    Journal of Proteome Research, Vol. 18, Núm. 12, pp. 4231-4239

  4. Platelet-rich plasma in osteoarthritis treatment: Review of current evidence

    Therapeutic Advances in Chronic Disease, Vol. 10, pp. 1-18

  5. Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis

    Therapeutic Advances in Chronic Disease, Vol. 10

2018

  1. What did we learn from 'omics' studies in osteoarthritis

    Current Opinion in Rheumatology, Vol. 30, Núm. 1, pp. 114-120

2017

  1. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications

    Expert Review of Proteomics, Vol. 14, Núm. 5, pp. 431-444